l-Arginine supplementation enhances eNOS expression in experimental model of hypercholesterolemic rabbits aorta

Pathophysiology - Tập 16 - Trang 9-13 - 2009
Shaghayegh Haghjooy Javanmard1, Mehdi Nematbakhsh1, Farzaneh Mahmoodi1, Mohamad Reza Mohajeri1
1Applied Physiology Research Center, Department of Physiology, Isfahan University of Medical Sciences, Isfahan, Iran

Tài liệu tham khảo

Napoli, 2006, Nitric oxide and atherosclerosis: an update, Nitric Oxide, 15, 265, 10.1016/j.niox.2006.03.011 Minor, 1990, Diet-induced atherosclerosis increases the release of nitrogen oxides from rabbit aorta, J. Clin. Invest., 86, 2109, 10.1172/JCI114949 Collin, 2007, Increased superoxide anion production is associated with early atherosclerosis and cardiovascular dysfunctions in a rabbit model, Mol. Cell. Biochem., 294, 225, 10.1007/s11010-006-9263-y Ignarro, 2005, Novel features of nitric oxide, endothelial nitric oxide synthase and atherosclerosis, Curr. Diab. Rep., 5, 17, 10.1007/s11892-005-0062-8 Cayatte, 1994, Chronic inhibition of nitric oxide production accelerates neointima formation and impairs endothelial function in hypercholesterolemic rabbits, Arterioscler. Thromb. Vasc. Biol., 14, 746, 10.1161/01.ATV.14.5.753 Wink, 1998, Chemical biology of nitric oxide: insights into regulatory, cytotoxic, and cytoprotective mechanisms of nitric oxide, Free. Radic. Biol. Med., 25, 434, 10.1016/S0891-5849(98)00092-6 Huang, 2003, Endothelial nitric oxide synthase and endothelial dysfunction, Curr. Hypertens. Rep., 5, 473, 10.1007/s11906-003-0055-4 Braam, 2007, Understanding eNOS for pharmacological modulation of endothelial function: a translational view, Curr. Pharm., 13, 1727, 10.2174/138161207780831275 Aktan, 2004, iNOS-mediated nitric oxide production and its regulation, Life. Sci., 75, 639, 10.1016/j.lfs.2003.10.042 Esaki, 1997, Expression of inducible nitric oxide synthase in T lymphocytes and macrophages of cholesterol-fed rabbits, Atherosclerosis, 128, 39, 10.1016/S0021-9150(96)05976-X Buttery, 1996, Inducible nitric oxide synthase is present within human atherosclerotic lesions and promotes the formation and activity of peroxynitrite, Lab. Invest., 75, 77 Yan, 1998, Overexpression of inducible nitric oxide synthase by neointimal smooth muscle cells, Circ. Res., 82, 21, 10.1161/01.RES.82.1.21 Wilcox, 1997, Expression of multiple isoforms of nitric oxide synthase in normal and atherosclerotic vessels, Arterioscler. Thromb. Vasc. Biol., 17, 2479, 10.1161/01.ATV.17.11.2479 Shears, 1997, Inducible nitric oxide synthase suppresses the development of allograft arteriosclerosis, J. Clin. Invest., 100, 2035, 10.1172/JCI119736 Kuhlencordt, 2001, Genetic deficiency of inducible nitric oxide synthase reduces atherosclerosis and lowers plasma lipid peroxides in apolipoprotein E-knockout mice, Circulation, 103, 3099, 10.1161/01.CIR.103.25.3099 Radi, 1991, Peroxynitrite oxidation of sulfhydryls: the cytotoxic potential of superoxide and nitric oxide, J. Biol. Chem., 266, 4244, 10.1016/S0021-9258(20)64313-7 Kuhlencordt, 2001, Accelerated atherosclerosis, aortic aneurysm formation, and ischemic heart disease in apolipoprotein E/endothelial nitric oxide synthase double-knockout mice, Circulation, 104, 448, 10.1161/hc2901.091399 Knowles, 2000, Enhanced atherosclerosis and kidney dysfunction in eNOS (−/−) Apoe (−/−) mice are ameliorated by enalapril treatment, J. Clin. Invest, 105, 451, 10.1172/JCI8376 Cooney, 2007, Effect of gene delivery of NOS isoforms on intimal hyperplasia and endothelial regeneration after balloon injury, Gene. Ther., 14, 396, 10.1038/sj.gt.3302882 Channon, 1998, In vivo gene transfer of nitric oxide synthase enhances vasomotor function in carotid arteries from normal and cholesterol-fed rabbits, Circulation, 98, 1905, 10.1161/01.CIR.98.18.1905 Miller, 2007, Recent developments in nitric oxide donor drugs, Br. J. Pharmacol., 151, 305, 10.1038/sj.bjp.0707224 Morris, 2006, Arginine: beyond protein, Am. J. Clin. Nutr., 83, 508S, 10.1093/ajcn/83.2.508S Kagemann, 2007, Limited availability of l-arginine increases DNA-binding activity of NF-kappaB and contributes to regulation of iNOS expression, J. Mol. Med., 85, 723, 10.1007/s00109-007-0168-3 Tousoulis, 2007, Mechanisms of disease: l-arginine in coronary atherosclerosis—a clinical perspective, Nat. Clin. Pract. Cardiovasc. Med., 4, 274, 10.1038/ncpcardio0878 Morris, 2004, Decreased arginine bioavailability and increased serum arginase activity in asthma, Am. J. Respir. Crit. Care Med., 170, 148, 10.1164/rccm.200309-1304OC Wittmann, 2005, l-Arginine improves wound healing after trauma-hemorrhage by increasing collagen synthesis, J. Trauma, 59, 162, 10.1097/01.TA.0000171529.06625.A8 Zhang, 2006, Influence of l-arginine on the expression of eNOS and COX2 in experimental pulmonary thromboembolism, J. Huazhong Univ. Sci. Technol. Med. Sci., 26, 524, 10.1007/s11596-006-0509-4 Cayatte, 1994, Chronic inhibition of nitric oxide production accelerates neointima formation and impairs endothelial function in hypercholesterolemic rabbits, Arterioscler. Thromb., 14, 753, 10.1161/01.ATV.14.5.753 Kauser, 2000, Role of endogenous nitric oxide in progression of atherosclerosis in apolipoprotein E-deficient mice, Am. J. Physiol. Heart. Circ. Physiol., 278, H1679, 10.1152/ajpheart.2000.278.5.H1679 Knowles, 2000, Enhanced atherosclerosis and kidney dysfunction in eNOS (−/−) Apoe (−/−) mice are ameliorated by enalapril treatment, J. Clin. Invest., 105, 451, 10.1172/JCI8376 Hayashi, 2004, Gene transfer of endothelial NO synthase, but not eNOS plus inducible NOS, regressed atherosclerosis in rabbits, Cardiovasc. Res., 61, 339, 10.1016/j.cardiores.2003.09.027 Mujynya-Ludunge, 2005, Endothelial nitric oxide synthase gene transfer restores endothelium-dependent relaxations and attenuates lesion formation in carotid arteries in apolipoprotein E-deficient mice, Basic Res. Cardiol., 100, 102, 10.1007/s00395-004-0500-9 Zanetti, 2003, In vivo gene transfer of inducible nitric oxide synthase to carotid arteries from hypercholesterolemic rabbits, Stroke, 34, 1293, 10.1161/01.STR.0000068366.00173.E7 Detmers, 2000, Deficiency in inducible nitric oxide synthase results in reduced atherosclerosis in apolipoprotein E-deficient mice, J. Immunol., 165, 3430, 10.4049/jimmunol.165.6.3430 Hayashi, 2006, Selective iNOS inhibitor, ONO1714 successfully retards the development of high-cholesterol diet induced atherosclerosis by novel mechanism, Atherosclerosis, 187, 316, 10.1016/j.atherosclerosis.2005.10.023